(Q62559160)
Statements
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study (English)
Stephan Petersenn
John Newell-Price
Feng Gu
Mario Maldonado
Andrew Trovato
Gareth Hughes
André Lacroix
Jochen Schopohl
Rosario Pivonello
James W Findling
Luiz R Salgado
Beverly M K Biller
Pasireotide B2305 Study Group